3,621
Views
9
CrossRef citations to date
0
Altmetric
Articles

Pregnancy outcomes after ultrasound-guided high-intensity focused ultrasound (USgHIFU) for conservative treatment of uterine fibroids: experience of a single institution

ORCID Icon, , , , , , , , & show all
Pages 9-17 | Received 15 Jan 2021, Accepted 21 Mar 2021, Published online: 23 Aug 2021

References

  • Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clin Evid. 2015;2015:0814.
  • Sparic R, Mirkovic L, Malvasi A, et al. Epidemiology of uterine Myomas: a review. Int J Fertil Steril. 2016;9(4):424–435.
  • Mills M, Rindfuss RR, McDonald P, et al. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update. 2011;17(6):848–860.
  • Balasch J, Gratacós E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Fetal Diagn Ther. 2011;29(4):263–273.
  • Somigliana E, De Benedictis S, Vercellini P, et al. Fibroids not encroaching the endometrial cavity and IVF success rate: a prospective study. Hum Reprod. 2011;26(4):834–839.
  • Galliano D, Bellver J, Díaz-García C, et al. ART and uterine pathology: how relevant is the maternal side for implantation? Hum Reprod Update. 2015;21(1):13–38.
  • Zepiridis LI, Grimbizis GF, Tarlatzis BC. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:66–73.
  • McWilliams MM, Chennathukuzhi VM. Recent advances in uterine fibroid etiology. Semin Reprod Med. 2017;35(2):181–189.
  • Cook H, Ezzati M, Segars JH, et al. The impact of uterine leiomyomas on reproductive outcomes. Minerva Ginecol. 2010;62(3):225–236.
  • Klatsky PC, Tran ND, Caughey AB, et al. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008;198(4):357–366.
  • Van der Kooij SM, Ankum WM, Hehenkamp WJ. Review of nonsurgical/minimally invasive treatments for uterine fibroids. Curr Opin Obstet Gynecol. 2012;24(6):368–375.
  • Casini ML, Rossi F, Agostini R, et al. Effects of the position of fibroids on fertility. Gynecol Endocrinol. 2006;22(2):106–109.
  • Olive DL. The surgical treatment of fibroids for infertility. Semin Reprod Med. 2011;29(2):113–123.
  • Practice Committee of the American Society for Reproductive Medicine. Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017;108(3):416–425.
  • Kumakiri J, Kikuchi I, Kitade M, et al. Association between uterine repair at laparoscopic myomectomy and postoperative adhesions. Acta Obstet Gynecol Scand. 2012;91(3):331–337.
  • Gambacorti-Passerini Z, Gimovsky AC, Locatelli A, et al. Trial of labor after myomectomy and uterine rupture: a systematic review. Acta Obstet Gynecol Scand. 2016;95(7):724–734.
  • Jacob GP, Oraif A, Power S. When helping hurts: the effect of surgical interventions on ovarian reserve. Hum Fertil. 2016;19(1):3–8.
  • Czuczwar P, Stępniak A, Wrona W, et al. The influence of uterine artery embolisation on ovarian reserve, fertility, and pregnancy outcomes – a review of literature. Prz Menopauzalny. 2016;15(4):205–209.
  • Holub Z, Mara M, Kuzel D, et al. Pregnancy outcomes after uterine artery occlusion: prospective multicentric study. Fertil Steril. 2008;90(5):1886–1891.
  • Goldberg J, Pereira L, Berghella V, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol. 2004;191(1):18–21.
  • Ravina JH, Vigneron NC, Aymard A, et al. Pregnancy after embolization of uterine myoma: report of 12 cases. Fertil Steril. 2000;73(6):1241–1243.
  • Pron G, Mocarski E, Bennett J, et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005;105(1):67–76.
  • Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010;94(1):324–330.
  • Gupta JK, Sinha A, Lumsden MA, et al. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014;(12):CD005073.
  • Cho HH, Kim JH, Kim MR. Transvaginal radiofrequency thermal ablation: a day-care approach to symptomatic uterine myomas. Aust NZ J Obstet Gynaecol. 2008;48(3):296–301.
  • Jiang X, Thapa A, Lu J, et al. Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas. Eur J Obstet Gynecol Reprod Biol. 2014;177:38–43.
  • Brölmann H, Bongers M, Garza-Leal JG, et al. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg. 2016;13(1):27–35.
  • Rey VE, Labrador R, Falcon M, et al. Transvaginal radiofrequency ablation of myomas: technique, outcomes, and complications. J Laparoendosc Adv Surg Tech A. 2019;29(1):24–28.
  • Wang F, Tang L, Wang L, et al. Ultrasound-guided high-intensity focused ultrasound vs laparoscopic myomectomy for symptomatic uterine myomas. J Minim Invasive Gynecol. 2014;21(2):279–284.
  • Chen J, Chen W, Zhang L, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–676.
  • Liu Y, Ran W, Shen Y, et al. High-intensity focused ultrasound and laparoscopic myomectomy in the treatment of uterine fibroids: a comparative study. BJOG: Int J Obstet Gy. 2017;124(Suppl. 3):36–39.
  • Cheung VYT. High-intensity focused ultrasound therapy. Best Pract Res Clin Obstet Gynaecol. 2018;46:74–83.
  • Zhang L, Zhang W, Orsi F, et al. Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: a review of safety and efficacy. Int J Hyperthermia. 2015;31(3):280–284.
  • Quinn SD, Vedelago J, Gedroyc W, et al. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2014;182:247–251.
  • Clark NA, Mumford SL, Segars JH. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence. Curr Opin Obstet Gynecol. 2014;26(3):151–161.
  • Cheung VY, Lam TP, Jenkins CR, et al. Ovarian reserve after ultrasound-guided high-intensity focused ultrasound for uterine fibroids: preliminary experience. J Obstet Gynaecol Can. 2016;38(4):357–361.
  • Rabinovici J, David M, Fukunishi H, et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93(1):199–209.
  • Zou M, Chen L, Wu C, et al. Pregnancy outcomes in patients with uterine fibroids treated with ultrasound-guided high-intensity focused ultrasound. BJOG: Int J Obstet Gy. 2017;124(Suppl. 3):30–35.
  • Li JS, Wang Y, Chen JY, et al. Pregnancy outcomes in nulliparous women after ultrasound ablation of uterine fibroids: a single-central retrospective study. Sci Rep. 2017;7(1):3977.
  • Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99(2):290–300.
  • Harding G, Coyne KS, Thompson CL, et al. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Health Qual Life Outcomes. 2008;6(1):99.
  • Smart OC, Hindley JT, Regan L, et al. Magnetic resonance guided focused ultrasound surgery of uterine fibroids–the tissue effects of GnRH agonist pre-treatment. Eur J Radiol. 2006;59(2):163–167.
  • Zhao WP, Chen JY, Chen WZ. Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images. Exp Ther Med. 2016;11(1):328–334.
  • Yang S, Kong F, Hou R, et al. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T2 weighted MR imaging. Br J Radiol. 2017;90(1073):20160760.
  • Peng S, Xiong Y, Li K, et al. Clinical utility of a microbubble-enhancing contrast (“SonoVue”) in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study. Eur J Radiol. 2012;81(12):3832–3838.
  • Wang YJ, Zhang PH, Zhang R, et al. Predictive value of quantitative uterine fibroid perfusion parameters from contrast-enhanced ultrasound for the therapeutic effect of High-Intensity Focused Ultrasound ablation. J Ultrasound Med. 2019;38(6):1511–1517.
  • Isern J, Pessarrodona A, Rodriguez J, et al. Using microbubble sonographic contrast agent to enhance the effect of high intensity focused ultrasound for the treatment of uterine fibroids. Ultrason Sonochem. 2015;27:688–693.
  • American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014;101(3):633–634.
  • Sudik R, Hüsch K, Steller J, et al. Fertility and pregnancy outcome after myomectomy in sterility patients. Eur J Obstet Gynecol Reprod Biol. 1996;65(2):209–214.
  • Dubuisson JB, Fauconnier A, Deffarges JV, et al. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod. 2000;15(4):869–873.
  • Soriano D, Dessolle L, Poncelet C, et al. Pregnancy outcome after laparoscopic and laparoconverted myomectomy. Eur J Obstet Gynecol Reprod Biol. 2003;108(2):194–198.
  • Kameda S, Toyoshima M, Tanaka K, et al. Utility of laparoscopic uterine myomectomy as a treatment for infertility with no obvious cause except for uterine fibroids. Gynecol Minim Invasive Ther. 2018;7(4):152–155.
  • Bernard G, Darai E, Poncelet C, et al. Fertility after hysteroscopic myomectomy: effect of intramural myomas associated. Eur J Obstet Gynecol Reprod Biol. 2000;88(1):85–90.
  • Donnez J, Donnez O, Dolmans MM. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertil Steril. 2014;102(3):640–648.
  • Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320(7251):1708–1712.
  • Radhika BH, Naik K, Shreelatha S, et al. Case series: pregnancy outcome in patients with uterine fibroids. J Clin Diagn Res. 2015;9(10):QR01–QR4.
  • Behbehani S, Polesello S, Hasson J, et al. The effect of intramural myomas without an intracavity component on in vitro fertilization outcomes in single fresh blastocyst transfer cycles. J Minim Invasive Gynecol. 2018;25(7):1241–1248.
  • Wang X, Chen L, Wang H, et al. The impact of noncavity-distorting intramural fibroids on the efficacy of in vitro fertilization-embryo transfer: an updated meta-analysis. Biomed Res Int. 2018;2018:8924703.
  • Lisiecki M, Paszkowski M, Woźniak S. Fertility impairment associated with uterine fibroids – a review of literature. Prz Menopauzalny. 2017;16(4):137–140.